Cargando…
Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy
Background: Prostate cancer (PCa) is considered one of the most important medical problems in the male population, with a very high incidence after the age of 65. Frailty represents one of the most critical issues facing healthcare due to its inherent relationship with poor healthcare outcomes. The...
Autores principales: | Mafla-España, Mayra Alejandra, Torregrosa, María Dolores, Beamud-Cortés, Manel, Bermell-Marco, Lorena, Rubio-Briones, José, Cauli, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178148/ https://www.ncbi.nlm.nih.gov/pubmed/37174808 http://dx.doi.org/10.3390/healthcare11091266 |
Ejemplares similares
-
Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy
por: Mafla-España, Mayra Alejandra, et al.
Publicado: (2023) -
Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review
por: Mafla-España, Mayra Alejandra, et al.
Publicado: (2023) -
Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
por: García-Sánchez, Javier, et al.
Publicado: (2022) -
Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer
por: García-Sánchez, Javier, et al.
Publicado: (2022) -
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
por: García-Sánchez, Javier, et al.
Publicado: (2022)